Skip to main contentSkip to main content
You are the owner of this article.
You have permission to edit this article.
alert top story

ECDHD seeing increased cases of COVID-19 in district, Platte County

  • 0

COVID-19 cases have more than doubled within the last week in Platte County and East-Central District Health Department (ECDHD), according to ECDHD data.

Platte County has seen 277 cases during the week of Jan. 2-8 while ECDHD (which covers Boone, Colfax, Nance and Platte counties) has had 491. Compared to the week of Dec. 26 to Jan. 1, Platte County and ECDHD were at 115 and 172 cases, respectively.

“The reason behind the increase in cases is likely due to the omicron variant, which has a very fast doubling rate among populations,” ECDHD Chief Public Health Officer Chuck Sepers said. “Since the genomic surveillance is so delayed, it will transmit much faster than it can be detected.”

However, the exact number of omicron variant cases isn’t known. Sepers said the Nebraska Department of Health and Human Services has detected one omicron variant case last week in the county. He added the Centers for Disease Control and Prevention tracker predicts around 77% of all cases within the region are omicron cases which means the prevalence is probably much higher.

A new U.S. Food and Drug Administration-approved medicine has been on the market to help combat COVID-19. The medicine – Paxlovid and Molnupiravir - can be found at Tooley’s Drug and Home Care, 2615 13th St.

“These treatments are being prescribed to patients by area providers based on qualifications,” Sepers said. “These antivirals reduce the symptoms of severe COVID-19 among those with mild to moderate symptoms that the patient’s medical provider believes are at risk for severe illness due to the patient’s medical history.

“COVID antivirals are extremely effective at reducing the risk of hospitalization and death to a high degree. For example, Paxlovid - a Pfizer-made product available to those 12 (and older) - reduced the risk of hospitalization or death by almost 90% in clinical trials.”

Sepers said Paxlovid may only be used by health care providers to treat mild-to-moderate COVID in adults and pediatric patients – who are 12 and older and weigh at least 88 pounds. It is used for those at high risk for severe COVID-19, including hospitalization and death, he added.

Meanwhile, Molnupiravir may only be used to treat mild-to-moderate COVID-19 in adults for whom alternative COVID-19 treatment options authorized by FDA are not accessible or clinically appropriate, according to Sepers. Molnupiravir is not authorized for use in patients younger than 18, he added.

Additionally, there has been a reported omicron-delta mutated variant, according to national reports. Scientists have called the strain “deltacron.” Sepers said the strain was more than likely due to a lab error, citing possible contamination. He added going forward he believes there will be new variants.

Overall, the omicron variant has not as severe as previous variants, Sepers said. However, it has the highest infection rate of any COVID variant compared to other strains that have been seen, he added.

“The day when we see a variant that is both more transmissible and more deadly than the other variants is just a matter of ‘when,’ not if,’” Sepers said.

Sepers said he understands most people “are largely burned out” from the COVID-19 pandemic but still folks are facing serious consequences if they are unvaccinated and not following mask guidelines seriously.

Sepers said ECDHD was notified on Jan. 7 about a 24-year-old resident of the health district that passed away from to COVID-related illness.

“This unvaccinated patient is the youngest resident to die to COVID-19 complications within the health district,” he said.

Andrew Kiser is a reporter for The Columbus Telegram. Reach him via email at


Get local news delivered to your inbox!

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

On Monday, Sarah Ehlers started the job she was made to do: Talent and Workforce Development Director for the Columbus Area Chamber of Commerce.

Get up-to-the-minute news sent straight to your device.


News Alerts

Breaking News